204 related articles for article (PubMed ID: 25368121)
1. Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes.
Huesa C; Zhu D; Glover JD; Ferron M; Karsenty G; Milne EM; Millan JL; Ahmed SF; Farquharson C; Morton NM; MacRae VE
Dis Model Mech; 2014 Dec; 7(12):1341-50. PubMed ID: 25368121
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast-specific deficiency of ectonucleotide pyrophosphatase or phosphodiesterase-1 engenders insulin resistance in high-fat diet fed mice.
Roberts FL; Rashdan NA; Phadwal K; Markby GR; Dillon S; Zoll J; Berger J; Milne E; Orriss IR; Karsenty G; Le Saux O; Morton NM; Farquharson C; MacRae VE
J Cell Physiol; 2021 Jun; 236(6):4614-4624. PubMed ID: 33305372
[TBL] [Abstract][Full Text] [Related]
3. Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice.
Mackenzie NC; Zhu D; Milne EM; van 't Hof R; Martin A; Darryl Quarles L; Millán JL; Farquharson C; MacRae VE
PLoS One; 2012; 7(2):e32177. PubMed ID: 22359666
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
Abate N; Chandalia M; Di Paola R; Foster DW; Grundy SM; Trischitta V
Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):694-701. PubMed ID: 17143316
[TBL] [Abstract][Full Text] [Related]
5. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.
Harmey D; Hessle L; Narisawa S; Johnson KA; Terkeltaub R; Millán JL
Am J Pathol; 2004 Apr; 164(4):1199-209. PubMed ID: 15039209
[TBL] [Abstract][Full Text] [Related]
6. ENPP1 gene, insulin resistance and related clinical outcomes.
Bacci S; De Cosmo S; Prudente S; Trischitta V
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):403-9. PubMed ID: 17563456
[TBL] [Abstract][Full Text] [Related]
7. Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1(-/-) mice.
Hajjawi MO; MacRae VE; Huesa C; Boyde A; Millán JL; Arnett TR; Orriss IR
Bone; 2014 Dec; 69():139-47. PubMed ID: 25260930
[TBL] [Abstract][Full Text] [Related]
8. Adipose Tissue Insulin Resistance in Gestational Diabetes.
Tumurbaatar B; Poole AT; Olson G; Makhlouf M; Sallam HS; Thukuntla S; Kankanala S; Ekhaese O; Gomez G; Chandalia M; Abate N
Metab Syndr Relat Disord; 2017 Mar; 15(2):86-92. PubMed ID: 28080219
[TBL] [Abstract][Full Text] [Related]
9. Metabolic consequences of ENPP1 overexpression in adipose tissue.
Pan W; Ciociola E; Saraf M; Tumurbaatar B; Tuvdendorj D; Prasad S; Chandalia M; Abate N
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E901-11. PubMed ID: 21810932
[TBL] [Abstract][Full Text] [Related]
10. Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.
Mahmut A; Boulanger MC; Bouchareb R; Hadji F; Mathieu P
Cardiovasc Res; 2015 Apr; 106(1):109-20. PubMed ID: 25644539
[TBL] [Abstract][Full Text] [Related]
11. Editorial: The pleiotropic effect of the ENPP1 (PC-1) gene on insulin resistance, obesity, and type 2 diabetes.
Prudente S; Trischitta V
J Clin Endocrinol Metab; 2006 Dec; 91(12):4767-8. PubMed ID: 17148571
[No Abstract] [Full Text] [Related]
12. New insights into NPP1 function: lessons from clinical and animal studies.
Mackenzie NC; Huesa C; Rutsch F; MacRae VE
Bone; 2012 Nov; 51(5):961-8. PubMed ID: 22842219
[TBL] [Abstract][Full Text] [Related]
13. Catalysis-Independent ENPP1 Protein Signaling Regulates Mammalian Bone Mass.
Zimmerman K; Liu X; von Kroge S; Stabach P; Lester ER; Chu EY; Srivastava S; Somerman MJ; Tommasini SM; Busse B; Schinke T; Carpenter TO; Oheim R; Braddock DT
J Bone Miner Res; 2022 Sep; 37(9):1733-1749. PubMed ID: 35773783
[TBL] [Abstract][Full Text] [Related]
14. Acidosis is a key regulator of osteoblast ecto-nucleotidase pyrophosphatase/phosphodiesterase 1 (NPP1) expression and activity.
Orriss IR; Key ML; Hajjawi MO; Millán JL; Arnett TR
J Cell Physiol; 2015 Dec; 230(12):3049-56. PubMed ID: 26033523
[TBL] [Abstract][Full Text] [Related]
15. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
Goldfine ID; Maddux BA; Youngren JF; Reaven G; Accili D; Trischitta V; Vigneri R; Frittitta L
Endocr Rev; 2008 Feb; 29(1):62-75. PubMed ID: 18199690
[TBL] [Abstract][Full Text] [Related]
16. Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice.
Anderson HC; Harmey D; Camacho NP; Garimella R; Sipe JB; Tague S; Bi X; Johnson K; Terkeltaub R; Millán JL
Am J Pathol; 2005 Jun; 166(6):1711-20. PubMed ID: 15920156
[TBL] [Abstract][Full Text] [Related]
17. Role of ENPP1 on adipocyte maturation.
Liang J; Fu M; Ciociola E; Chandalia M; Abate N
PLoS One; 2007 Sep; 2(9):e882. PubMed ID: 17849011
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5.
Yang D; Turner AG; Wijenayaka AR; Anderson PH; Morris HA; Atkins GJ
Mol Cell Endocrinol; 2015 Sep; 412():140-7. PubMed ID: 26054750
[TBL] [Abstract][Full Text] [Related]
19. Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1.
Vaingankar SM; Fitzpatrick TA; Johnson K; Goding JW; Maurice M; Terkeltaub R
Am J Physiol Cell Physiol; 2004 May; 286(5):C1177-87. PubMed ID: 15075217
[TBL] [Abstract][Full Text] [Related]
20. ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children.
Böttcher Y; Körner A; Reinehr T; Enigk B; Kiess W; Stumvoll M; Kovacs P
J Clin Endocrinol Metab; 2006 Dec; 91(12):4948-52. PubMed ID: 16968801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
